| Model Number |
305C27 |
| Medical Device Problem Codes |
Calcified (1077); Gradient Increase (1270); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Calcium Deposits/Calcification (1758); Aortic Valve Insufficiency/ Regurgitation (4450)
|
| Date of Event |
08/24/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that 16 years and 6 months post implant of this 27mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was reported as high gradient.Evidence of calcification was seen under left coronary cusp (lcc) extending into the left ventricular outflow tract (lvot) and in the proximal right coronary artery (rca).No intervention or adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
Additional information received reported that an intervention is planned for (b)(6)2026.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
B2, b5, h1 and imf (annex f) code were updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|